Skip to main content
SpringerLink
Log in

Variceal bleeding

  • Conference paper
Pathogenesis and Clinical Practice in Gastroenterology

Part of the book series: Falk Symposium ((FASS,volume 160))

  • 621 Accesses

Abstract

Variceal bleeding is caused by portal hypertension, which can be assessed by measurement of the gradient between the wedged hepatic venous pressure and the free hepatic venous pressure (HVPG). A threshold of 10 mmHg is associated with the formation of collaterals to bypass splanchnic venous blood through the liver1,2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Le Moine O, Hadengue A, Moreau R et al. Relationship between portal pressure. esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis. Scand J Gastroenterol. 1997;32:731–5.

    Article  PubMed  Google Scholar 

  2. Groszmann RJ, Garcia-Tsao G, Bosch J et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254–61.

    Article  PubMed  CAS  Google Scholar 

  3. Rigau J, Bosch J, Bordas JM et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989;96:873–80.

    PubMed  CAS  Google Scholar 

  4. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5:419–24.

    Article  PubMed  CAS  Google Scholar 

  5. Barton R, Rosch J, Saxon R, Lakin P. TIPS: short-and long-term results; a survey of 1750 patients. Semin Intervent Radiol. 1995:364–7.

    Google Scholar 

  6. McCormick PA, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;49:682–5.

    Article  PubMed  CAS  Google Scholar 

  7. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–9.

    Article  PubMed  Google Scholar 

  8. Merkel C, Marin R, Angeli P et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 2004;127:476–84.

    Article  PubMed  CAS  Google Scholar 

  9. Trebicka J, Hennenberg M, Laleman W et al. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology. 2007;46:242–53.

    Article  PubMed  CAS  Google Scholar 

  10. Trebicka J, Neef M, Hennenberg M et al. Atorvastatin inhibits fibrogenesis through inhibition of activation of hepatic stellate cells. J Hepatol. 2007;46:S134.

    Article  Google Scholar 

  11. Zafra C, Abraldes JG, Turnes J et al. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology. 2004;126:749–55.

    Article  PubMed  CAS  Google Scholar 

  12. Schepke M, Werner E, Biecker E et al. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology. 2001;121:389–95.

    Article  PubMed  CAS  Google Scholar 

  13. Croquet V, Moal F, Veal N et al. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol. 2002;37:773–80.

    Article  PubMed  CAS  Google Scholar 

  14. Sookoian S, Fernandez MA, Castano G. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. World J Gastroenterol. 2005;11:7560–3.

    PubMed  CAS  Google Scholar 

  15. Rincon D, Ripoll C, Lo Iacono O et al. Antiviral therapy decreases hepatic ven ous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am J Gastroenterol. 2006;101:2269–74.

    Article  PubMed  CAS  Google Scholar 

  16. Trebicka J, Leifeld L, Hennenberg M et al. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats. Hepatology. 2008;47:1264–76.

    Article  PubMed  CAS  Google Scholar 

  17. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988:319:983–9.

    Google Scholar 

  18. Kleber G, Sauerbruch T, Fischer G, Paumgartner G. Pressure of intraoesophageal varices assessed by fine needle puncture: its relation to endoscopic signs and severity of liver disease in patients with cirrhosis. Gut. 1989;30:228–32.

    Article  PubMed  CAS  Google Scholar 

  19. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med. 1991;324:1532–8.

    PubMed  CAS  Google Scholar 

  20. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120:726–48.

    Article  PubMed  CAS  Google Scholar 

  21. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther. 2005;21:347–61.

    Article  PubMed  CAS  Google Scholar 

  22. Schepke M, Kleber G, Nurnberg D et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65–72.

    Article  PubMed  Google Scholar 

  23. Banares R, Moitinho E, Piqueras B et al. Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology. 1999;30:79–83.

    Article  PubMed  CAS  Google Scholar 

  24. Ioannou GN, Kowdley KV. Review: Antibiotic prophylaxis reduces mortality and bacterial infection in cirrhosis and gastrointestinal bleeding. ACP J Club. 2002;137:94.

    PubMed  Google Scholar 

  25. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–76.

    Article  PubMed  Google Scholar 

  26. Sung JJ, Chung SC, Yung MY et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet. 1995;346:1666–9.

    Article  PubMed  CAS  Google Scholar 

  27. Cales P, Masliah C, Bernard B et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med. 2001;344:23–8.

    Article  PubMed  CAS  Google Scholar 

  28. Garcia-Pagan JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol 2005;2:526–35.

    Article  PubMed  Google Scholar 

  29. Gross M, Schiemann U, Muhlhofer A, Zoller WG. Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy. 2001;33:737–46.

    Article  PubMed  CAS  Google Scholar 

  30. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–61.

    Article  PubMed  CAS  Google Scholar 

  31. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology. 1997;25:63–70.

    Article  PubMed  CAS  Google Scholar 

  32. de la Pena J, Brullet E, Sanchez-Hernandez E et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005;41:572–8.

    Article  PubMed  Google Scholar 

  33. Study Group Spanish Cooperative Variceal Rebleeding. Multicenter RCT comparing drug therapy vs combination of drug therapy+endoscopic variceal ligation in the prevention of rebleeding in patients with cirrhosis. Hepatology. 2006;44:202A.

    Google Scholar 

  34. Villanueva C, Minana J, Ortiz J et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001;345:647–55.

    Article  PubMed  CAS  Google Scholar 

  35. Henderson JM, Boyer TD, Kutner MH et al. DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130:1643–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik I, University of Bonn, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany

    T. Sauerbruch

Authors
  1. T. Sauerbruch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Trebicka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Gastroenterology, Medical Centre Ljubljana, Slovenia

    I. Ferkolj

  2. University of Vienna, Vienna, Austria

    A. Gangl

  3. University of Mainz, Mainz, Germany

    P. R. Galle

  4. University Hospital Rebro, Zagreb, Croatia

    B. Vucelic

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer and Falk Foundation e.V.

About this paper

Cite this paper

Sauerbruch, T., Trebicka, J. (2008). Variceal bleeding. In: Ferkolj, I., Gangl, A., Galle, P.R., Vucelic, B. (eds) Pathogenesis and Clinical Practice in Gastroenterology. Falk Symposium, vol 160. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8767-7_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-8767-7_22

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-8766-0

  • Online ISBN: 978-1-4020-8767-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation